Clinical Trial Update: Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia [NA]

View source ↗

Summary

A clinical trial evaluating transcranial direct current stimulation for hallucinations in first-episode schizophrenia has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis Nos
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Transcranial Direct Current Stimulation (transcranial direct current stimulation)

Snippet

Sponsor: Northwell Health | Conditions: Schizophrenia, Schizophreniform | NA | Status: WITHDRAWN